<DOC>
	<DOCNO>NCT01145053</DOCNO>
	<brief_summary>To investigate safety effectiveness information use Tiotropium Respimat long time period daily practical clinical circumstance , obtain proper drug use information .</brief_summary>
	<brief_title>Drug Use Survey RESPIMAT Patients With COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Inclusion criterion : Patients COPD expect treatable long term . All patient must diagnosis COPD register start treatment Tiotropium Respimat . Exclusion criterion : There special restriction , PMS observational investigation condition normal clinical practice . Spiriva Respimat contraindicate patient hypersensitivity Tiotropium bromide , atropine derivative , e.g . ipratropium oxitropium excipients Package labelling .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>